# Expanded Access of Omegaven IV Fat Emulsion to Infants and Children With PNALD

> **NCT02929303** · — · APPROVED_FOR_MARKETING · sponsor: **Wake Forest University Health Sciences**

## Conditions studied

- Total Parenteral Nutrition-induced Cholestasis

## Interventions

- **DRUG:** Omegaven IV lipid emulsion

## Key facts

- **NCT ID:** NCT02929303
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** APPROVED_FOR_MARKETING
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2025-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02929303

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02929303, "Expanded Access of Omegaven IV Fat Emulsion to Infants and Children With PNALD". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02929303. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*